MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
November 14, 2022
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
October 5, 2022